Source:http://linkedlifedata.com/resource/pubmed/id/20864524
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
48
|
pubmed:dateCreated |
2010-11-24
|
pubmed:abstractText |
One of the important questions in the field of virus research is about the balance between latent and lytic cycles of replication. Kaposi's sarcoma-associated herpesvirus (KSHV) remains predominantly in a latent state, with only 1-3% of cells supporting a lytic replication at any time. KSHV glycoprotein B (gB) is expressed not only on the virus envelope but also on the surfaces of the few cells supporting lytic replication. Using co-culture experiments, we determined that expression of KSHV gB on as few as 1-2% of human dermal microvascular endothelial cells resulted in a 10-fold inhibition of expression of ORF50, a viral gene critical for the onset of lytic replication. Also, we demonstrate that such a profound inhibitory effect of gB on the lytic cycle of virus replication is by repressing the ability of Egr-1 (early growth response-1) to bind and activate the ORF50 promoter. In general, virus-encoded late stage structural proteins, such as gB, are said to play major roles in virus entry and egress. The present report provides initial evidence supporting a role for membrane-associated gB expressed in a minimal number of cells to promote virus latency. These findings may have ramifications leading to a better understanding of the role of virus-encoded structural proteins not only in KSHV-related diseases but also in other viruses causing latent infections.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Single-Stranded,
http://linkedlifedata.com/resource/pubmed/chemical/DNA enzyme ED5,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Envelope Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/glycoprotein B, human herpesvirus 8
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1083-351X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
26
|
pubmed:volume |
285
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
37491-502
|
pubmed:dateRevised |
2011-1-6
|
pubmed:meshHeading |
pubmed-meshheading:20864524-Cell Membrane,
pubmed-meshheading:20864524-Cells, Cultured,
pubmed-meshheading:20864524-DNA, Single-Stranded,
pubmed-meshheading:20864524-Endothelial Cells,
pubmed-meshheading:20864524-Gene Expression Regulation,
pubmed-meshheading:20864524-Gene Expression Regulation, Viral,
pubmed-meshheading:20864524-Herpesvirus 8, Human,
pubmed-meshheading:20864524-Humans,
pubmed-meshheading:20864524-Sarcoma, Kaposi,
pubmed-meshheading:20864524-Viral Envelope Proteins,
pubmed-meshheading:20864524-Virus Latency
|
pubmed:year |
2010
|
pubmed:articleTitle |
Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.
|
pubmed:affiliation |
Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, North Carolina 27834, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|